Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Cancer Gene Ther. 2012 Apr 20;19(7):443–450. doi: 10.1038/cgt.2012.14

Figure 5. VSV-IFN oncolysis of orthotopic 5TGM1 myeloma.

Figure 5

Bone marrows harvested 48h post IV PBS, VSV-mIFNβ or VSV-hIFNβ administration processed for H&E (magnification 200x). Arrows indicate regions of cellular necrosis.